Found: 3
Select item for more details and to access through your institution.
Impact of a Best Practices Program in Patients with Relapsed/Refractory Multiple Myeloma Receiving Selinexor.
- Published in:
- Current Oncology, 2024, v. 31, n. 1, p. 501, doi. 10.3390/curroncol31010034
- By:
- Publication type:
- Article
Pharmacist-led patient education and adverse event management in patients with non-small cell lung cancer receiving afatinib in a community-based, real-world clinical setting.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 1, p. 13, doi. 10.1177/1078155219833441
- By:
- Publication type:
- Article
EXPERT COMMENTARY ON THE PRODUCT PROFILE OF Belzutifan for Renal Cell Carcinoma.
- Published in:
- Oncology (08909091), 2022, v. 36, n. 1, p. 64
- By:
- Publication type:
- Article